Response of fractional synthesis rate (FSR) of fibrinogen, concentration of D-dimer and fibrinolytic balance to physical activity-based intervention in obese children

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 8, 2008, Pages 1296-1303

  Balagopal, Prabhakaran ^a   George, D ^a   Sweeten, S ^a   Mann, K J ^a   Yarandi, H ^b   Mauras, N ^a   Vaughan, D E ^c  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Fibrinogen; Fibrinolysis; Obesity; Physical activity; Synthesis rate

Indexed keywords

D DIMER; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ARTICLE; BLOOD CLOTTING PARAMETERS; BODY MASS; CHILD CARE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN DEFECT; FIBRINOGEN SYNTHESIS; FIBRINOLYSIS; FRACTIONAL SYNTHESIS RATE; HUMAN; HYPERCOAGULABILITY; HYPERFIBRINOGENEMIA; LEAN BODY WEIGHT; LIFESTYLE MODIFICATION; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; EXERCISE; EXERCISE THERAPY; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FIBRINOLYSIS; HUMANS; KINETICS; LIFE STYLE; MALE; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 47749097975     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03037.x     Document Type: Article

References (43)

1. JuhanVague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34: 457-62.
2. Sobel BE. Increased plasminogen activator inhibitor-1 and vasculopathy: a reconcilable paradox. Circulation 1999; 99: 2496-8.
3. Vaughan DE. Plasminogen activator inhibitor-1 and vascular disease in diabetes mellitus. In: Johnstone MT, Veves A, eds. Diabetes and Cardiovascular Disease. New Jersey: Humana Press Inc, 2001: 237-43.
4. McDermott MM, Greenland P, Green D, Guralnik JM, Criqui MH, Liu K, Chan C, Pearce WH, Taylor L, Ridker PM, Schneider JR, Martin G, Rifai N, Quann M, Fornage M. D-Dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation 2003; 107: 3191-8.
5. Alessi MC, Poggi M, Juhan-Vague I. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol 2007; 18: 240-5.
6. Blair SN, Kohl HW III, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 1995; 273: 1093-8.
7. Sallis JF, Patterson TL, Buono MJ, Nader PR. Relation of cardiovascular fitness and physical activity to cardiovascular disease risk factors in children and adults. Am J Epidemiol 1988; 127: 933-41.
8. Marcus BH, Williams DM, Dubbert PM, Sallis JF, King AC, Yancey AK, Franklin BA, Buchner D, Daniels SR, Claytor RP. Physical activity intervention studies: What we knoA and what we need to know: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity); Council on cardiovascular disease in the young; and the Interdisciplinary Working Group on quality of care and outcomes research. Circulation 2006; 114: 2739-52.
9. Isasi CR, Starc TJ, Tracy RP, Deckelbaum R, Berglund L, Shea S. Inverse association of physical fitness with plasma fibrinogen level in children the Columbia University BioMarkers Study. Am J Epidemiol 2000; 152: 212-8.
10. Imhof A, Koenig W. Exercise and thrombosis. Cardiol Clin 2001; 19: 389-400.
11. Ferguson MA, Gutin B, Owens S, Barbeau P, Tracy RP, Litaker M. Effects of physical training and its cessation on the hemostatic system of obese children. Am J Clin Nutr 1999; 69: 1130-4.
12. Balagopal P, George D, Patton N, Yarandi H, Roberts WL, Bayne E, Gidding S. Lifestyle-only intervention attenuates the inflammatory state associated with obesity - a randomized controlled study in adolescents. J Pediatr 2005; 146: 342-8.
13. Montgomery HE, Clarkson P, Nwose OM, Mikailidis DP, Jagroop IA, Dollery C, Moult J, Benhizia F, Deanfield J, Jubb M, World M, McEwan JR, Winder A, Humphries S. The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the fibrinogen gene. Arterioscler Thromb Vasc Biol 1996; 16: 386-91.
14. Stratton JR, Chadler WL, Schwartz RS, Cerqueira MD, Levy WC, Kahn SE, Larson VG, Cain KC, Beard JC, Abrass IB. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 1991; 83: 1692-7.
15. Waterlow JC, Garlick PJ, Millward DJ. Protein Turnover in Mammalian Tissues and in the Whole Body. Amsterdam: Elsevier/North-Holland Biomedical Press, 1978.
16. Umpaichitra V, Hussain M, Castells S. Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity. Pediatr Res 2005; 58: 483-7.
17. Balagopal P, George D, Yarandi H, Funanage V, Bayne E. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: A controlled, randomized study in obese adolescents. J Clin Endocrinol Metab 2005; 90: 6192-7.
18. Mellin LM, Slinkard LA, Irwin CE. Adolescent obesity intervention: validation of the SHAPEDOWN program. J Am Diet Assoc 1987; 87: 333-8.
19. Matthews DE, Motil KJ, Rohrbaugh DK, Burke JF, Young VR, Bier DM. Measurement of leucine metabolism in man from a primed, continuous infusion of L-[13C] leucine. Am J Physiol 1980; 238: E473-9.
20. 13C] leucine enrichment in human muscle protein. Anal Biochem 1996; 239: 77-85.
21. De Feo P, Volpi E, Lucidi P, Cruciani G, Reboldi G, Siepi D, Mannarino E, Santeusanio F, Brunetti P, Bolli GB. Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. Diabetes 1993; 42: 995-1002.
22. Jahoor F, Sivakumar B, Del Rosario M, Frazer EM. Isolation of acute-phase proteins from plasma for determination of fractional synthesis rates by a stable isotope tracer technique. Anal Biochem 1996; 236: 95-100.
23. Vaughan DE, Rouleau JL, Ridker PM, Arnold JM, Menapace FJ, Pfeffer MA. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. Circulation 1997; 96: 442-7.
24. Hoffman JJ, Landolfi R. Automated nephelometry of fibrinogen: Analytical performance and observations during thrombolytic therapy. Clin Chem 1998; 34: 2135-40.
25. Balagopal P, Sweeten S, Mauras N. Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents. Am J Physiol 2002; 282: E899-904.
26. Volpi E, Lucidi P, Bolli GB, Santeusanio F, De Feo P. Gender differences in basal protein kinetics in young adults. J Clin Endocrinol Metab 1998; 83: 4363-7.
27. De Feo P, Gaisano MG, Haymond MW. Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest 1991; 88: 833-40.
28. Gauldie J, Northemann W, Fey GH. IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. J Immunol 1990; 144: 3804-8.
29. Baumann H, Jahreis GP, Morella KK, Won KA, Pruitt SC, Jones VE, Prowse KR. Transcriptional regulation through cytokine and glucocorticoid response elements of rat acute phase plasma protein genes by C/EBP and JunB. J Biol Chem 1991; 266: 20390-9.
30. von Kañel R, Kudielka BM, Hanebuth D, Preckel D, Fischer JE. Different contribution of interleukin-6 and cortisol activity to total plasma fibrin concentration and to acute mental stress-induced fibrin formation. Clin Sci 2005; 109: 61-7.
31. Hunter KA, Garlick PJ, Broom I, Anderson E, McNurlan MA. Effects of smoking and abstention from smoking on fibrinogen synthesis in humans. Clin Sci 2001; 100: 459-65.
32. Fu AZ, Nair KS. Age effect on fibrinogen and albumin synthesis in humans. Am J Physiol 1998; 275: E1023-30.
33. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992; 80: 1998-2005.
34. Solano MP, Perry AC, Wang X, Ross R, Goldberg RB. Insulin resistance but not visceral adipose tissue is associated with plasminogen activator inhibitor type 1 levels in overweight and obese premenopausal African-American women. Int J Obes 2003; 27: 82-7.
35. Morange PE, Aubert J, Peiretti F, Lijnen HR, Vague P, Verdier M, Negrel R, Juhan-Vague I, Alessi MC. Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes 1999; 48: 890-5.
36. Oishi K, Ohkura N, Wakabayashi M, Shirai H, Sato K, Matsuda J, Atsumi G, Ishida N. Clock is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression. J Thromb Haemost 2006; 4: 1774-80.
37. Vind J, Gleerup G, Nielsen PT, Winther K. The impact of static work on fibrinolysis and platelet function. Thromb Res 1993; 72: 441-6.
38. El-Sayed MS. Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation. Sports Med 1996; 22: 282-98.
39. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GDO. Fibrin D-Dimer and coronary heart disease: Prospective study and meta-analysis. Circulation 2001; 103: 2323-7.
40. Cushman M, Folsom AR, Wang L, Aleksic N, Rosamond WD, Tracy RP, Heckbert SR. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 2003; 101: 1243-8.
41. Ferguson MA, Gutin B, Owens S, Litaker M, Tracy RP, Allison J. Fat distribution and hemostatic measures in obese children. Am J Clin Nutr 1998; 67: 1136-40.
42. Naski MC, Shafer JA. A kinetic model for the alpha-thrombin-catalyzed conversion of plasma levels of fibrinogen to fibrin in the presence of antithrombin III. J Biol Chem 1991; 266: 13003-10.
43. Rudnicka AR, Rumley A, Lowe GDO, Strachan DP. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-Dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 2007; 115: 996-1003.